Synopsis: This company share can deliver up to 63 percent upside, driven by strong Q4 FY26 pre-sales of Rs 20,100 crore and sustained demand in the luxury housing segment.
The share of this company, which specializes in producing complex molecules and finished dosage formulations, including liquids, injectables, capsules, and oncology drugs, gained traction after a strong Q4.
With a market capitalization of Rs 1,45,226 crore, DLF Ltd’s share closed at Rs 587 per share, down by 0.24 percent from its previous close. The share of the company delivered a return of 118 percent over the last five years.
Brokerage View
Citi on DLF
Citi maintained a Buy rating on DLF Ltd with a target price of Rs 770, citing strong brand positioning and steady demand outlook as key growth drivers. Citi noted that DLF Ltd reported Q4 FY26 pre-sales of Rs 20,100 crore, which was in line with the lower end of its guidance range. This performance reflects steady demand momentum in the company’s core residential portfolio despite a high base and premium pricing strategy.
Management has guided for FY27 pre-sales of around Rs 20,000 crore, supported by planned launches of four key projects during the year. The outlook indicates a calibrated growth approach, with emphasis on sustaining sales velocity rather than aggressive expansion.
Citi also highlighted strong demand in the ultra-luxury segment, particularly the 32 Dahlias units sold during Q4 FY26. The brokerage further emphasized DLF’s strong brand equity and premium positioning in the real estate market as key long-term growth drivers supporting sustained performance.
HSBC on DLF
HSBC maintains a Buy rating on DLF Ltd with a target price of Rs 920, implying around 57 percent upside from close, supported by strong execution, robust pre-sales momentum, and improving cash flows.
HSBC highlighted that DLF Ltd reported better-than-expected pre-sales, supported by strong momentum in its Dahlias project. The company’s residential execution remained strong, while cash generation continued to improve during the quarter, reflecting healthy operational efficiency across projects.
Collections stood at Rs 13,517 crore, marking a 15 percent YoY growth and indicating record-level performance. Surplus cash increased to Rs 7,746 crore, up 25 percent YoY, supported by strong inflows and disciplined capital management. The net cash position strengthened further to Rs 14,155 crore, while RERA’s 70 percent account balance stood at Rs 11,215 crore, reflecting a robust liquidity position.
HSBC also noted the strength of DLF’s commercial portfolio, which spans around 50 million square feet with a GAV of Rs 89,780 crore. Occupancy levels remained high at 95 percent by area and 97 percent by value, ensuring stable rental income. Overall, strong execution and a resilient commercial portfolio are expected to support sustained growth in the residential business going forward.
Conclusion: DLF Ltd continues to benefit from strong demand in the luxury housing segment, supported by robust Q4 FY26 pre-sales and healthy growth in collections. The company’s strong brand positioning, improving cash balance, and successful execution across premium projects continue to strengthen investor confidence despite softer year-on-year revenue performance.
Brokerages remain positive on the company due to its resilient commercial portfolio, strong occupancy levels, and planned launches in FY27. With management guiding for sustained pre-sales momentum and brokerages projecting up to 63 percent upside, DLF Ltd appears well-positioned to maintain steady long-term growth in the premium real estate market.
About the Company
DLF Ltd, with its subsidiaries, associates, and JVs, is engaged in real estate development, from the identification and acquisition of land to planning, execution, construction, and marketing of projects. It is also engaged in the business of leasing, generation of power, provision of maintenance services, hospitality, and recreational services, which are related to the overall development of the real estate business.
Financial Highlight: The revenue from operations decreased by 42 percent to Rs 1,814 crore in Q4 FY26 (Mar 2026) from Rs 3,128 crore in Q4 FY25 (Mar 2025), and EBIDT decreased by 58 percent to Rs 411 crore in Q4 FY26 from Rs 978 crore in Q4 FY25. This was accompanied by a net profit decline of 3 percent to Rs 1,269 crore in Q4 FY26 from Rs 1,282 crore in Q4 FY25, resulting in an EPS decrease of 1 percent to Rs 5.12 per share in Q4 FY26 from Rs 5.18 per share in Q4 FY25.
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
The post Financially Strong Stock to Buy Now for an Upside of 63%; Do You Own It? appeared first on Trade Brains.
Original Article
(Disclaimer – This post is auto-fetched from publicly available RSS feeds. Original source: Tradebrains. All rights belong to the respective publisher.)
